SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
DNA X, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)
Close on Oct 19, 2026
- Market cap
- $4.47M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2017 to 2025
Gross margin
–
Operating margin
–
Net margin
–
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
9 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2017 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -111.0% | 302.6% | |
| Return on assets | – | -56.6% | -49.4% | |
| Current ratio | – | 2.23 | 0.57 | |
| Debt to equity | – | 0.01 | – | |
| Net debt to EBITDA | – | 0.82× | – | |
| Interest coverage | – | – | -5.7× | |
| Inventory turnover | – | 3.2× | – | |
| Capex to revenue | – | 0.0% | – | |
| Diluted shares | – | 0M | 1M |
Cash use needs five years of cash flow figures
DNA X does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-57.7%
×Asset turnover1.22×
×Equity multiplier5.75×
=Return on equity, FY2024-403.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2024 | -57.7% | 1.22× | 5.75× | -403.7% |
| FY2023 | -0.1% | 1.71× | 2.59× | -0.4% |
| FY2022 | -20.2% | 1.47× | 2.45× | -72.8% |
| FY2021 | -70.8% | 1.19× | 1.94× | -164.2% |
| FY2020 | -46.8% | 1.21× | 1.96× | -111.0% |
| FY2019 | -22.2% | 1.89× | 4.01× | -168.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
1of 6 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$20.66M
- Cash generatingOperating cash flow above zero-$23.53M
- Return on assets improvedROA up on the prior year-60.0% → -52.0%
- Earnings backed by cashOperating cash flow above net income-$23.53M vs -$20.66M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose0.74 → 0.57
- No dilutionShare count did not rise0M → 1M
- Gross margin improvedGross margin up on the prior year17.02% → –
- More efficientAsset turnover rose1.04 → –